Respiratory cluster f&$)!

Discussion in 'GlaxoSmithKline' started by anonymous, Jul 12, 2016 at 10:19 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Sounds good to me but the next layoff won't factor sales in at all. everything will be subjective if they use the current ranking system
     

  2. anonymous

    anonymous Guest

    To get back to see the physician I sometimes have to leave advair samples. What happens is that the office does not need anoro samples but they do need Advair which buys me time to get to see the physician. But, my Breo rep does not want me to leave Advair for obvious reasons. I only leave a very limited quantity of Advair, but he still cries and whines about it. Are any other reps having the same problem with their Breo reps?
     
  3. anonymous

    anonymous Guest

    Yes, of course, but most of that comes from a moron manager who is pressuring the Breo rep in that manner. The new Anoro members from the Tanzeum CVMU side still get Levitra samples. If the company had half a brain it would provide a limited quantity of Ventolin samples to Anoro reps to help us with access. The explanation they provided us for not having Ventolin samples is pure loser/failure to solve a problem - something we are all used to by now.
     
  4. anonymous

    anonymous Guest

    So, do you leave advair Samples when it buys you access or do you not?
     
  5. anonymous

    anonymous Guest

    Of course I leave Advair samples, only a complete loser wouldn't. Keep it to a minimum though, I only want access - not interested in making life more difficult for Breo counterpart.
     
  6. anonymous

    anonymous Guest

    Predicting half the number of representatives selling the entire Ellipta portfolio with a maximum of 2 per larger territory. One with a COPD lead, followed by asthma, and the other with an asthma lead followed by a COPD discussion. Accountability for sales performance, in some way or another, either objective or subjective, or a combination of both, occurs immediately following the end of the CIA in June of 2017. It's Ellipta versus the world in preparation for closed-triple Q3 or Q4 2017 with a solid portfolio and step-therapy strategy, once/day, same device, lower co-pays, versus generic Advair and poorly positioned Spiriva and Asmanex. We'll be fine. Well, half of us will be.
     
  7. anonymous

    anonymous Guest

    Wow, our manager has seven freaking reps. He will be in these freaking officers way more than any of us. How many offices do you think are even available to bring a manager in? Why in the hell did they even do a manager realignment and keep all these people? Stuck on stupid!
     
  8. anonymous

    anonymous Guest

    Remember the days of 7 Advair reps in a territory? 5 Anoro scripts can give you a 40% mkt share in a mkt that includes Spiriva and these chumps still can't hit it. The Anoro reps aren't even close to generating one salary in sales per territory much less TWO salaries. GSK missed the boat on Breo plus INCRUSE. Dumb dumb dumb. Breo plus Incruse would have owed that mkt.
     
  9. anonymous

    anonymous Guest

    remember very clearly, not my fault, dime me out
     
  10. anonymous

    anonymous Guest

    Went into an easy to see walk in office with boss man yesterday. Got a call today asking why she has been here 3 times in the last week? Talk about screwing up a good thing?
     
  11. anonymous

    anonymous Guest

    Went into an easy to see walk in office with boss man yesterday. Got a call today asking why she has been here 3 times in the last week? Talk about screwing up a good thing?
     
  12. anonymous

    anonymous Guest

    The company thinks that these offices are here just to entertain our managers! We have a real problem with management overload and it will bite us in the ass!
     
  13. anonymous

    anonymous Guest

    Yeah it's hilarious to bring them into the same offices and force more awkward convos. We got this! Back off!
     
  14. anonymous

    anonymous Guest

    Same thing here....have been asked 4 times in the last 2 weeks why we are in the offices so often and these are offices that are very rep friendly! Probably not so much for too much longer!
     
  15. advair rep

    advair rep Guest

    News Flash: Managed care today wants a "new" in the same class to be be 20% better in outcomes and the same price or a lower price. The volume will make up the difference.

    ECO: 101....dumb shits!
     
  16. anonymous

    anonymous Guest

    You made the decision to take the manager into the office. Why not bring them to a hard to see office to see if they can give you advice as to how you might be able to do better with the harder offices.
     
  17. anonymous

    anonymous Guest

    And what advice could they probably offer? Most offices with difficult access have either had bad experiences with previous reps from other companies or have realized they are working longer days and they run behind when they see reps. When they realize I am paying my staff to work later because I run late when I see reps, why would they they want to see reps. They are paid to see patients!!! They can see at least 5 more patients in the time it takes to see a handful reps. It's business 101. What advice could a manager offer to counteract common sense. We are lucky to get into the offices we can and are destroying relationships with this "see them until you get kicked out" strategy.
     
  18. anonymous

    anonymous Guest

    Because at the end of the day, boss man gonna judge you with a skewed eye if you have not seen a bunch of docs and we all know that! So I will not take a chance on docs that have a low probability of seeing me. We have all seen the FCR when that happens: "well Willy we only saw two doctors today but I am sure with better planning and routing that will improve!" Have that happen once or twice and I go back to the "dog and pony show"!
     
  19. anonymous

    anonymous Guest

    Amen
     
  20. anonymous

    anonymous Guest

    The whole freaking pharmaceutical sales industry has become a total joke from top to bottom. How it has lasted this long is truly unbelievable! What has enabled this to happen is that so many of our big drugs have been a license to print money that this procedure has been allowed to survive. And the management in big pharma has been awash in cash which has allowed them to contnue their imbecilic programs. Meanwhile, don't look for any changes soon!